PTJ
BBNX

Paul Tudor Jones’s Beta Bionics BBNX Stock Holding History

Paul Tudor Jones’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1,000K Sell
63,809
-154,285
-71% -$1.83M ﹤0.01% 2418
2026
Q1 		$2.19M Sell
218,094
-41,538
-16% -$614K ﹤0.01% 1782
2025
Q4 		$7.91M Buy
259,632
+221,039
+573% +$5.9M 0.01% 867
2025
Q3 		$767K Buy
+38,593
New +$678K ﹤0.01% 2445

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Paul Tudor Jones's BBNX Position: Q2 2026 in Review

Paul Tudor Jones reduced its Beta Bionics (BBNX) stake by 71% in Q2 2026, selling an estimated $1.83M and leaving 63,809 shares worth $1,000K. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

Paul Tudor Jones first reported a position in BBNX in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.91M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Paul Tudor Jones held 63,809 shares of Beta Bionics worth $1,000K as of Q2 2026.
  • Paul Tudor Jones sold 154,285 Beta Bionics shares in Q2 2026, an estimated $1.83M.
  • Beta Bionics made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2418 holding.
  • Paul Tudor Jones first reported a position in Beta Bionics in Q3 2025 and has held it in 4 quarters since.
  • Paul Tudor Jones's Beta Bionics position peaked at $7.91M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.